Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.61400409 |
2 | L-phenylalanine catabolic process (GO:0006559) | 6.61400409 |
3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.36579763 |
4 | L-phenylalanine metabolic process (GO:0006558) | 6.36579763 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 5.89657773 |
6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.73268945 |
7 | alpha-linolenic acid metabolic process (GO:0036109) | 5.71893109 |
8 | bile acid biosynthetic process (GO:0006699) | 5.29740039 |
9 | kynurenine metabolic process (GO:0070189) | 5.28571725 |
10 | indole-containing compound catabolic process (GO:0042436) | 5.27925019 |
11 | indolalkylamine catabolic process (GO:0046218) | 5.27925019 |
12 | tryptophan catabolic process (GO:0006569) | 5.27925019 |
13 | glyoxylate metabolic process (GO:0046487) | 5.24487528 |
14 | complement activation, alternative pathway (GO:0006957) | 5.06446601 |
15 | sulfur amino acid catabolic process (GO:0000098) | 5.02857417 |
16 | tryptophan metabolic process (GO:0006568) | 5.02397596 |
17 | urea metabolic process (GO:0019627) | 5.00988016 |
18 | urea cycle (GO:0000050) | 5.00988016 |
19 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.98722222 |
20 | cysteine metabolic process (GO:0006534) | 4.98170778 |
21 | negative regulation of fibrinolysis (GO:0051918) | 4.90913803 |
22 | high-density lipoprotein particle remodeling (GO:0034375) | 4.85403544 |
23 | regulation of protein activation cascade (GO:2000257) | 4.81039126 |
24 | regulation of triglyceride catabolic process (GO:0010896) | 4.80614537 |
25 | protein carboxylation (GO:0018214) | 4.79624785 |
26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.79624785 |
27 | lysine metabolic process (GO:0006553) | 4.77965874 |
28 | lysine catabolic process (GO:0006554) | 4.77965874 |
29 | low-density lipoprotein particle clearance (GO:0034383) | 4.75512068 |
30 | regulation of fibrinolysis (GO:0051917) | 4.66698871 |
31 | cell adhesion mediated by integrin (GO:0033627) | 4.61696337 |
32 | nitrogen cycle metabolic process (GO:0071941) | 4.61082456 |
33 | amino-acid betaine metabolic process (GO:0006577) | 4.53917187 |
34 | bile acid metabolic process (GO:0008206) | 4.53477943 |
35 | regulation of complement activation (GO:0030449) | 4.52456417 |
36 | serine family amino acid catabolic process (GO:0009071) | 4.47866282 |
37 | triglyceride homeostasis (GO:0070328) | 4.42289895 |
38 | acylglycerol homeostasis (GO:0055090) | 4.42289895 |
39 | tyrosine metabolic process (GO:0006570) | 4.39725660 |
40 | plasma lipoprotein particle clearance (GO:0034381) | 4.39166761 |
41 | aromatic amino acid family metabolic process (GO:0009072) | 4.34309183 |
42 | homocysteine metabolic process (GO:0050667) | 4.33440584 |
43 | plasma lipoprotein particle remodeling (GO:0034369) | 4.28349537 |
44 | protein-lipid complex remodeling (GO:0034368) | 4.28349537 |
45 | macromolecular complex remodeling (GO:0034367) | 4.28349537 |
46 | reverse cholesterol transport (GO:0043691) | 4.27775604 |
47 | alpha-amino acid catabolic process (GO:1901606) | 4.23804533 |
48 | skin morphogenesis (GO:0043589) | 4.23320785 |
49 | regulation of cholesterol esterification (GO:0010872) | 4.22633382 |
50 | cellular ketone body metabolic process (GO:0046950) | 4.22232700 |
51 | ethanol oxidation (GO:0006069) | 4.20490874 |
52 | endodermal cell differentiation (GO:0035987) | 4.17115674 |
53 | fatty acid beta-oxidation (GO:0006635) | 4.11911004 |
54 | acetyl-CoA metabolic process (GO:0006084) | 4.11247652 |
55 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 4.08378077 |
56 | phospholipid efflux (GO:0033700) | 4.06826182 |
57 | peptidyl-proline hydroxylation (GO:0019511) | 4.06267297 |
58 | Golgi transport vesicle coating (GO:0048200) | 4.03495126 |
59 | COPI coating of Golgi vesicle (GO:0048205) | 4.03495126 |
60 | protein hydroxylation (GO:0018126) | 4.02869585 |
61 | fatty acid oxidation (GO:0019395) | 3.99074036 |
62 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.97566691 |
63 | cellular amino acid catabolic process (GO:0009063) | 3.94617930 |
64 | valine metabolic process (GO:0006573) | 3.94555079 |
65 | coenzyme catabolic process (GO:0009109) | 3.92547291 |
66 | lipid oxidation (GO:0034440) | 3.92545767 |
67 | short-chain fatty acid metabolic process (GO:0046459) | 3.90980485 |
68 | bile acid and bile salt transport (GO:0015721) | 3.90564271 |
69 | positive regulation of lipid catabolic process (GO:0050996) | 3.90540243 |
70 | 2-oxoglutarate metabolic process (GO:0006103) | 3.90243671 |
71 | cellular glucuronidation (GO:0052695) | 3.88290271 |
72 | negative regulation of cholesterol transport (GO:0032375) | 3.88081111 |
73 | negative regulation of sterol transport (GO:0032372) | 3.88081111 |
74 | fatty acid catabolic process (GO:0009062) | 3.85495449 |
75 | fatty acid transmembrane transport (GO:1902001) | 3.84167103 |
76 | phospholipid homeostasis (GO:0055091) | 3.83894874 |
77 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.81765033 |
78 | collagen fibril organization (GO:0030199) | 3.80692109 |
79 | glycine metabolic process (GO:0006544) | 3.80403904 |
80 | monocarboxylic acid catabolic process (GO:0072329) | 3.78546804 |
81 | ketone body metabolic process (GO:1902224) | 3.76099747 |
82 | indolalkylamine metabolic process (GO:0006586) | 3.73542718 |
83 | cellular modified amino acid catabolic process (GO:0042219) | 3.72029497 |
84 | carboxylic acid catabolic process (GO:0046395) | 3.70776351 |
85 | organic acid catabolic process (GO:0016054) | 3.70776351 |
86 | regulation of plasminogen activation (GO:0010755) | 3.68188358 |
87 | glutamate metabolic process (GO:0006536) | 3.67600306 |
88 | serine family amino acid metabolic process (GO:0009069) | 3.66187080 |
89 | carnitine metabolic process (GO:0009437) | 3.66062241 |
90 | aldehyde catabolic process (GO:0046185) | 3.63463986 |
91 | benzene-containing compound metabolic process (GO:0042537) | 3.62746096 |
92 | low-density lipoprotein particle remodeling (GO:0034374) | 3.61625007 |
93 | cholesterol efflux (GO:0033344) | 3.61619194 |
94 | amine catabolic process (GO:0009310) | 3.61509869 |
95 | cellular biogenic amine catabolic process (GO:0042402) | 3.61509869 |
96 | negative regulation of lipase activity (GO:0060192) | 3.59898038 |
97 | plasma lipoprotein particle assembly (GO:0034377) | 3.59550481 |
98 | imidazole-containing compound metabolic process (GO:0052803) | 3.58779098 |
99 | protein heterotrimerization (GO:0070208) | 3.58107838 |
100 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.57327353 |
101 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.55634598 |
102 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.53387295 |
103 | fibrinolysis (GO:0042730) | 3.53106770 |
104 | aspartate family amino acid catabolic process (GO:0009068) | 3.49712631 |
105 | positive regulation of fatty acid oxidation (GO:0046321) | 3.47628460 |
106 | arginine metabolic process (GO:0006525) | 3.47146067 |
107 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.46981811 |
108 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.46981811 |
109 | regulation of sequestering of triglyceride (GO:0010889) | 3.46411295 |
110 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.45574656 |
111 | carnitine shuttle (GO:0006853) | 3.45505524 |
112 | biotin metabolic process (GO:0006768) | 3.45031975 |
113 | regulation of cholesterol metabolic process (GO:0090181) | 3.44661181 |
114 | uronic acid metabolic process (GO:0006063) | 3.44456318 |
115 | glucuronate metabolic process (GO:0019585) | 3.44456318 |
116 | cholesterol homeostasis (GO:0042632) | 3.43846197 |
117 | apoptotic cell clearance (GO:0043277) | 3.42584011 |
118 | COPII vesicle coating (GO:0048208) | 3.42199748 |
119 | basement membrane organization (GO:0071711) | 3.33023662 |
120 | protein retention in ER lumen (GO:0006621) | 3.32321900 |
121 | muscle filament sliding (GO:0030049) | 3.29158266 |
122 | actin-myosin filament sliding (GO:0033275) | 3.29158266 |
123 | polyketide metabolic process (GO:0030638) | 3.20791039 |
124 | doxorubicin metabolic process (GO:0044598) | 3.20791039 |
125 | daunorubicin metabolic process (GO:0044597) | 3.20791039 |
126 | membrane raft organization (GO:0031579) | 3.19672094 |
127 | actin-mediated cell contraction (GO:0070252) | 3.14755648 |
128 | negative regulation of protein localization to plasma membrane (GO:1903077) | 3.14345118 |
129 | cell-substrate junction assembly (GO:0007044) | 3.13598781 |
130 | pinocytosis (GO:0006907) | 3.13446485 |
131 | negative regulation of fatty acid transport (GO:2000192) | 3.12640215 |
132 | hypotonic response (GO:0006971) | 3.11390547 |
133 | protein localization to endosome (GO:0036010) | 3.08543445 |
134 | hyaluronan catabolic process (GO:0030214) | 3.08156861 |
135 | NADH metabolic process (GO:0006734) | 3.06926717 |
136 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.06654307 |
137 | 4-hydroxyproline metabolic process (GO:0019471) | 3.05370963 |
138 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.03653977 |
139 | positive regulation of extracellular matrix organization (GO:1903055) | 2.98805253 |
140 | cell migration involved in heart development (GO:0060973) | 2.96185037 |
141 | blood vessel maturation (GO:0001955) | 2.95351776 |
142 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.95256726 |
143 | chondrocyte proliferation (GO:0035988) | 2.94083130 |
144 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.93583246 |
145 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.92588924 |
146 | fatty acid homeostasis (GO:0055089) | 2.91799474 |
147 | regulation of metalloenzyme activity (GO:0048552) | 2.90863442 |
148 | triglyceride catabolic process (GO:0019433) | 2.89476431 |
149 | type B pancreatic cell proliferation (GO:0044342) | 2.87884244 |
150 | stress fiber assembly (GO:0043149) | 2.87657074 |
151 | barbed-end actin filament capping (GO:0051016) | 2.87334928 |
152 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.84948076 |
153 | substrate-dependent cell migration (GO:0006929) | 2.83806721 |
154 | wound healing, spreading of epidermal cells (GO:0035313) | 2.83417208 |
155 | hemidesmosome assembly (GO:0031581) | 2.83386663 |
156 | cellular response to vitamin (GO:0071295) | 2.82525999 |
157 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.81980451 |
158 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.81101478 |
159 | extracellular fibril organization (GO:0043206) | 2.79628740 |
160 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.75476798 |
161 | glomerular basement membrane development (GO:0032836) | 2.74342659 |
162 | response to muscle activity (GO:0014850) | 2.73545503 |
163 | tricarboxylic acid cycle (GO:0006099) | 2.72997933 |
164 | protein maturation by protein folding (GO:0022417) | 2.72497648 |
165 | sarcomere organization (GO:0045214) | 2.72312631 |
166 | sprouting angiogenesis (GO:0002040) | 2.71998928 |
167 | platelet degranulation (GO:0002576) | 2.65816137 |
168 | endothelial cell morphogenesis (GO:0001886) | 2.64198117 |
169 | negative regulation of anoikis (GO:2000811) | 2.63533196 |
170 | collagen metabolic process (GO:0032963) | 2.62955251 |
171 | kidney mesenchyme development (GO:0072074) | 2.62182172 |
172 | vesicle coating (GO:0006901) | 2.57568447 |
173 | neutral lipid catabolic process (GO:0046461) | 2.56141702 |
174 | acylglycerol catabolic process (GO:0046464) | 2.56141702 |
175 | muscle cell cellular homeostasis (GO:0046716) | 2.53819557 |
176 | extracellular matrix disassembly (GO:0022617) | 2.51168755 |
177 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.50648839 |
178 | venous blood vessel morphogenesis (GO:0048845) | 2.50343438 |
179 | positive regulation of receptor recycling (GO:0001921) | 2.50124493 |
180 | tricarboxylic acid metabolic process (GO:0072350) | 2.49988467 |
181 | AMP metabolic process (GO:0046033) | 2.48482432 |
182 | protein localization to cell surface (GO:0034394) | 2.47248594 |
183 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.46531075 |
184 | regulation of early endosome to late endosome transport (GO:2000641) | 2.46059453 |
185 | cardiac myofibril assembly (GO:0055003) | 2.45544473 |
186 | actin filament-based movement (GO:0030048) | 2.45383297 |
187 | fibril organization (GO:0097435) | 2.44991631 |
188 | focal adhesion assembly (GO:0048041) | 2.44681286 |
189 | cell-substrate adherens junction assembly (GO:0007045) | 2.44681286 |
190 | positive regulation of osteoblast proliferation (GO:0033690) | 2.43913079 |
191 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.43412445 |
192 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.42869928 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.71743854 |
2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.82717435 |
3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.69538224 |
4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.19453436 |
5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.99934495 |
6 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.91684122 |
7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.80237433 |
8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.66896917 |
9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.16636962 |
10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.76720548 |
11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.62567083 |
12 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.15292688 |
13 | * HIF1A_21447827_ChIP-Seq_MCF-7_Human | 3.11838148 |
14 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.77095756 |
15 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 2.53313183 |
16 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 2.36696126 |
17 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.33538589 |
18 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.31428672 |
19 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.18904985 |
20 | CJUN_26792858_Chip-Seq_BT549_Human | 2.17056093 |
21 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 2.07185157 |
22 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 2.04410521 |
23 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.03493162 |
24 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.02788716 |
25 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.8412514 |
26 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.98744619 |
27 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.94220820 |
28 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.94220820 |
29 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.89387662 |
30 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.87735441 |
31 | GATA1_22025678_ChIP-Seq_K562_Human | 1.80795908 |
32 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.80385856 |
33 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.77873878 |
34 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.77119662 |
35 | * MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.70220047 |
36 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.65959691 |
37 | * NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.64296312 |
38 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.64106065 |
39 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.63320204 |
40 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.63058781 |
41 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.60517591 |
42 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.53177611 |
43 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.52491798 |
44 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.51089014 |
45 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.47717655 |
46 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.45255546 |
47 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.42576216 |
48 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.42037810 |
49 | ATF3_27146783_Chip-Seq_COLON_Human | 1.35342892 |
50 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.27798925 |
51 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.26234240 |
52 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.24899344 |
53 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.24015462 |
54 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.21135378 |
55 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.20014533 |
56 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16744614 |
57 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.14959175 |
58 | * TP53_22127205_ChIP-Seq_IMR90_Human | 1.14478408 |
59 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.14418710 |
60 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.13336189 |
61 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.12241036 |
62 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.10553465 |
63 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09553996 |
64 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.07470164 |
65 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.06685501 |
66 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.06521694 |
67 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.04923948 |
68 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.04570981 |
69 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.02779339 |
70 | TP53_16413492_ChIP-PET_HCT116_Human | 1.01719288 |
71 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.98155770 |
72 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.97558076 |
73 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.96509093 |
74 | * TFEB_21752829_ChIP-Seq_HELA_Human | 0.96237801 |
75 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.95148788 |
76 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.94875023 |
77 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.93774175 |
78 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.93087618 |
79 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.91884525 |
80 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.90738199 |
81 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.89998465 |
82 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.89726978 |
83 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.89302229 |
84 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.88206576 |
85 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.87384822 |
86 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.86713865 |
87 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.84875623 |
88 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.84125228 |
89 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.83648278 |
90 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.82995461 |
91 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.81961045 |
92 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.79894825 |
93 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.79648966 |
94 | NFI_21473784_ChIP-Seq_ESCs_Mouse | 0.79033471 |
95 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.78929626 |
96 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.78555180 |
97 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.78162194 |
98 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.78055277 |
99 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.76153033 |
100 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.75974866 |
101 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.75898162 |
102 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.75516259 |
103 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.74338375 |
104 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.74338375 |
105 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.73830379 |
106 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.73204342 |
107 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.69883865 |
108 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.69005829 |
109 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.68660716 |
110 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.67574901 |
111 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.67574901 |
112 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.66634224 |
113 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.64794908 |
114 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.64453172 |
115 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.63856366 |
116 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.63574201 |
117 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.62921092 |
118 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.62844114 |
119 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.62820489 |
120 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.61123786 |
121 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.58758197 |
122 | GATA2_19941826_ChIP-Seq_K562_Human | 0.58698174 |
123 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.57291477 |
124 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.57041262 |
125 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.56686336 |
126 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.56393093 |
127 | GATA1_19941826_ChIP-Seq_K562_Human | 0.56023472 |
128 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.55783363 |
129 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.54653765 |
130 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.53444401 |
131 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.53029200 |
132 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.52961201 |
133 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.52334264 |
134 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.50209584 |
135 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.48793031 |
136 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.48333573 |
137 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.47430430 |
138 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.47372951 |
139 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.47314723 |
140 | CBP_21632823_ChIP-Seq_H3396_Human | 0.47112891 |
141 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.46578793 |
142 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.46048222 |
143 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.45299508 |
144 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.44873812 |
145 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.44683865 |
146 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.44578534 |
147 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.44332305 |
148 | * ERG_20517297_ChIP-Seq_VCAP_Human | 0.43599892 |
149 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.42903284 |
150 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.42429685 |
151 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.42032169 |
152 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.41702480 |
153 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.40730839 |
154 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.40546362 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 7.53591981 |
2 | MP0005360_urolithiasis | 6.59147720 |
3 | MP0008438_abnormal_cutaneous_collagen | 6.41182774 |
4 | MP0005365_abnormal_bile_salt | 5.82650344 |
5 | MP0005085_abnormal_gallbladder_physiolo | 5.70472869 |
6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.53460441 |
7 | MP0003806_abnormal_nucleotide_metabolis | 3.88249188 |
8 | MP0004272_abnormal_basement_membrane | 3.74416186 |
9 | MP0003950_abnormal_plasma_membrane | 3.68155673 |
10 | MP0010329_abnormal_lipoprotein_level | 3.55909756 |
11 | MP0003252_abnormal_bile_duct | 3.51395730 |
12 | MP0009840_abnormal_foam_cell | 3.13650828 |
13 | MP0005275_abnormal_skin_tensile | 2.85046063 |
14 | MP0003279_aneurysm | 2.77205920 |
15 | MP0005083_abnormal_biliary_tract | 2.76907525 |
16 | MP0000751_myopathy | 2.76188747 |
17 | MP0005332_abnormal_amino_acid | 2.62838144 |
18 | MP0003566_abnormal_cell_adhesion | 2.51500012 |
19 | MP0003191_abnormal_cellular_cholesterol | 2.41101490 |
20 | MP0003195_calcinosis | 2.40726228 |
21 | MP0001958_emphysema | 2.34223932 |
22 | MP0001666_abnormal_nutrient_absorption | 2.30230542 |
23 | MP0000749_muscle_degeneration | 2.26057977 |
24 | MP0000609_abnormal_liver_physiology | 2.25203778 |
25 | MP0002877_abnormal_melanocyte_morpholog | 2.25123402 |
26 | MP0002118_abnormal_lipid_homeostasis | 2.22371891 |
27 | MP0005623_abnormal_meninges_morphology | 2.09589815 |
28 | MP0005257_abnormal_intraocular_pressure | 2.07335588 |
29 | MP0005503_abnormal_tendon_morphology | 2.06455353 |
30 | MP0004084_abnormal_cardiac_muscle | 2.04497759 |
31 | MP0000013_abnormal_adipose_tissue | 1.95483066 |
32 | MP0005319_abnormal_enzyme/_coenzyme | 1.93557733 |
33 | MP0005670_abnormal_white_adipose | 1.87755296 |
34 | MP0006054_spinal_hemorrhage | 1.84568753 |
35 | MP0004019_abnormal_vitamin_homeostasis | 1.79991522 |
36 | MP0003091_abnormal_cell_migration | 1.79250728 |
37 | MP0004130_abnormal_muscle_cell | 1.78989104 |
38 | MP0005023_abnormal_wound_healing | 1.76363819 |
39 | MP0002138_abnormal_hepatobiliary_system | 1.74919151 |
40 | MP0004233_abnormal_muscle_weight | 1.73122037 |
41 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.71396881 |
42 | MP0003868_abnormal_feces_composition | 1.70824870 |
43 | MP0010352_gastrointestinal_tract_polyps | 1.69716751 |
44 | MP0009780_abnormal_chondrocyte_physiolo | 1.66364578 |
45 | MP0000759_abnormal_skeletal_muscle | 1.63772446 |
46 | MP0000747_muscle_weakness | 1.62190456 |
47 | MP0001764_abnormal_homeostasis | 1.60443025 |
48 | MP0003186_abnormal_redox_activity | 1.58844823 |
49 | MP0009697_abnormal_copulation | 1.54973481 |
50 | MP0000767_abnormal_smooth_muscle | 1.53102709 |
51 | MP0002060_abnormal_skin_morphology | 1.50169468 |
52 | MP0003011_delayed_dark_adaptation | 1.49217313 |
53 | MP0000003_abnormal_adipose_tissue | 1.47734214 |
54 | MP0002837_dystrophic_cardiac_calcinosis | 1.43941147 |
55 | MP0006036_abnormal_mitochondrial_physio | 1.38723963 |
56 | MP0000733_abnormal_muscle_development | 1.38685327 |
57 | MP0005451_abnormal_body_composition | 1.35589290 |
58 | MP0002971_abnormal_brown_adipose | 1.34648854 |
59 | MP0005666_abnormal_adipose_tissue | 1.33482751 |
60 | MP0001542_abnormal_bone_strength | 1.32766709 |
61 | MP0009643_abnormal_urine_homeostasis | 1.31699438 |
62 | MP0000750_abnormal_muscle_regeneration | 1.28153949 |
63 | MP0003828_pulmonary_edema | 1.27432021 |
64 | MP0005165_increased_susceptibility_to | 1.27068584 |
65 | MP0003941_abnormal_skin_development | 1.25859681 |
66 | MP0006138_congestive_heart_failure | 1.25771628 |
67 | MP0008775_abnormal_heart_ventricle | 1.25541272 |
68 | MP0005164_abnormal_response_to | 1.23032590 |
69 | MP0000598_abnormal_liver_morphology | 1.22790470 |
70 | MP0002295_abnormal_pulmonary_circulatio | 1.19645865 |
71 | MP0002108_abnormal_muscle_morphology | 1.16840741 |
72 | MP0002106_abnormal_muscle_physiology | 1.16739076 |
73 | MP0003656_abnormal_erythrocyte_physiolo | 1.16431478 |
74 | MP0003705_abnormal_hypodermis_morpholog | 1.15428503 |
75 | MP0002896_abnormal_bone_mineralization | 1.14679934 |
76 | MP0002972_abnormal_cardiac_muscle | 1.12427256 |
77 | MP0009763_increased_sensitivity_to | 1.11157252 |
78 | MP0001879_abnormal_lymphatic_vessel | 1.11068926 |
79 | MP0009764_decreased_sensitivity_to | 1.10516388 |
80 | MP0002254_reproductive_system_inflammat | 1.06839574 |
81 | MP0005369_muscle_phenotype | 1.06443169 |
82 | MP0001915_intracranial_hemorrhage | 1.05044563 |
83 | MP0005334_abnormal_fat_pad | 1.04476048 |
84 | MP0005620_abnormal_muscle_contractility | 1.01544273 |
85 | MP0001243_abnormal_dermal_layer | 1.01482122 |
86 | MP0008469_abnormal_protein_level | 1.00487956 |
87 | MP0002078_abnormal_glucose_homeostasis | 0.99929932 |
88 | MP0004145_abnormal_muscle_electrophysio | 0.99468003 |
89 | MP0000604_amyloidosis | 0.96890021 |
90 | MP0010368_abnormal_lymphatic_system | 0.96085121 |
91 | MP0004510_myositis | 0.95960841 |
92 | MP0005535_abnormal_body_temperature | 0.95960582 |
93 | MP0005508_abnormal_skeleton_morphology | 0.92822726 |
94 | MP0005647_abnormal_sex_gland | 0.92654753 |
95 | MP0003724_increased_susceptibility_to | 0.92596072 |
96 | MP0005171_absent_coat_pigmentation | 0.90905447 |
97 | MP0005408_hypopigmentation | 0.89299385 |
98 | MP0001299_abnormal_eye_distance/ | 0.88955758 |
99 | MP0009642_abnormal_blood_homeostasis | 0.88240436 |
100 | MP0002128_abnormal_blood_circulation | 0.85611026 |
101 | MP0005636_abnormal_mineral_homeostasis | 0.84168301 |
102 | MP0005595_abnormal_vascular_smooth | 0.83977520 |
103 | MP0010630_abnormal_cardiac_muscle | 0.83536587 |
104 | MP0005376_homeostasis/metabolism_phenot | 0.80428277 |
105 | MP0003646_muscle_fatigue | 0.79093253 |
106 | MP0006035_abnormal_mitochondrial_morpho | 0.78194963 |
107 | MP0001661_extended_life_span | 0.77080177 |
108 | MP0004185_abnormal_adipocyte_glucose | 0.76294116 |
109 | MP0004215_abnormal_myocardial_fiber | 0.75748672 |
110 | MP0000858_altered_metastatic_potential | 0.74700113 |
111 | MP0009115_abnormal_fat_cell | 0.74190669 |
112 | MP0005266_abnormal_metabolism | 0.73504675 |
113 | MP0005058_abnormal_lysosome_morphology | 0.72563493 |
114 | MP0005375_adipose_tissue_phenotype | 0.71863315 |
115 | MP0001614_abnormal_blood_vessel | 0.71060039 |
116 | MP0002876_abnormal_thyroid_physiology | 0.69857633 |
117 | MP0009250_abnormal_appendicular_skeleto | 0.69653647 |
118 | MP0005448_abnormal_energy_balance | 0.69639577 |
119 | MP0005464_abnormal_platelet_physiology | 0.69626260 |
120 | MP0003436_decreased_susceptibility_to | 0.69209266 |
121 | MP0005084_abnormal_gallbladder_morpholo | 0.69057798 |
122 | MP0004484_altered_response_of | 0.68658449 |
123 | MP0005330_cardiomyopathy | 0.68640630 |
124 | MP0005220_abnormal_exocrine_pancreas | 0.68633046 |
125 | MP0001853_heart_inflammation | 0.68572693 |
126 | MP0009765_abnormal_xenobiotic_induced | 0.67747813 |
127 | MP0005197_abnormal_uvea_morphology | 0.67527915 |
128 | MP0002166_altered_tumor_susceptibility | 0.65496782 |
129 | MP0002970_abnormal_white_adipose | 0.64976146 |
130 | MP0003690_abnormal_glial_cell | 0.63400024 |
131 | MP0002168_other_aberrant_phenotype | 0.61948106 |
132 | MP0002998_abnormal_bone_remodeling | 0.61466513 |
133 | MP0001756_abnormal_urination | 0.61055767 |
134 | MP0003448_altered_tumor_morphology | 0.60935235 |
135 | MP0003045_fibrosis | 0.60101157 |
136 | MP0003221_abnormal_cardiomyocyte_apopto | 0.53114410 |
137 | MP0002269_muscular_atrophy | 0.50589046 |
138 | MP0009785_altered_susceptibility_to | 0.50227640 |
139 | MP0000249_abnormal_blood_vessel | 0.49501225 |
140 | MP0002136_abnormal_kidney_physiology | 0.48869934 |
141 | MP0003329_amyloid_beta_deposits | 0.47041178 |
142 | MP0000343_altered_response_to | 0.45968642 |
143 | MP0000230_abnormal_systemic_arterial | 0.45228071 |
144 | MP0003953_abnormal_hormone_level | 0.44998846 |
145 | MP0001845_abnormal_inflammatory_respons | 0.43818642 |
146 | MP0003075_altered_response_to | 0.43017660 |
147 | MP0001881_abnormal_mammary_gland | 0.42952471 |
148 | MP0002928_abnormal_bile_duct | 0.42910205 |
149 | MP0008873_increased_physiological_sensi | 0.42797514 |
150 | MP0004036_abnormal_muscle_relaxation | 0.42451526 |
151 | MP0004782_abnormal_surfactant_physiolog | 0.42402720 |
152 | MP0003959_abnormal_lean_body | 0.42359513 |
153 | MP0001544_abnormal_cardiovascular_syste | 0.42254713 |
154 | MP0005385_cardiovascular_system_phenoty | 0.42254713 |
155 | MP0000639_abnormal_adrenal_gland | 0.42059619 |
156 | MP0009384_cardiac_valve_regurgitation | 0.41968897 |
157 | MP0004087_abnormal_muscle_fiber | 0.40858860 |
158 | MP0002332_abnormal_exercise_endurance | 0.39856063 |
159 | MP0003300_gastrointestinal_ulcer | 0.39734299 |
160 | MP0006082_CNS_inflammation | 0.39546355 |
161 | MP0003638_abnormal_response/metabolism_ | 0.39270380 |
162 | MP0005166_decreased_susceptibility_to | 0.38047925 |
163 | MP0005167_abnormal_blood-brain_barrier | 0.37791552 |
164 | MP0009672_abnormal_birth_weight | 0.36798895 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 6.40037585 |
2 | Protrusio acetabuli (HP:0003179) | 6.39567284 |
3 | Premature rupture of membranes (HP:0001788) | 6.36443148 |
4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.30047556 |
5 | Intrahepatic cholestasis (HP:0001406) | 6.29632208 |
6 | Xanthomatosis (HP:0000991) | 5.73827209 |
7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.59092556 |
8 | Prolonged partial thromboplastin time (HP:0003645) | 5.57798346 |
9 | Hypobetalipoproteinemia (HP:0003563) | 5.53260081 |
10 | Hyperlipoproteinemia (HP:0010980) | 5.12519865 |
11 | Type 1 muscle fiber predominance (HP:0003803) | 5.07009768 |
12 | Complement deficiency (HP:0004431) | 4.85695001 |
13 | Hyperammonemia (HP:0001987) | 4.70458377 |
14 | Hypoglycemic coma (HP:0001325) | 4.68437497 |
15 | Hypolipoproteinemia (HP:0010981) | 4.46005818 |
16 | Ketosis (HP:0001946) | 4.42347295 |
17 | Hyperglycinuria (HP:0003108) | 4.27262896 |
18 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.23050610 |
19 | Hyperglycinemia (HP:0002154) | 4.22322056 |
20 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.19075897 |
21 | Nemaline bodies (HP:0003798) | 4.16742767 |
22 | Epidermoid cyst (HP:0200040) | 4.16670671 |
23 | Joint hemorrhage (HP:0005261) | 4.15978963 |
24 | Muscle fiber inclusion bodies (HP:0100299) | 4.12875038 |
25 | Hypoalphalipoproteinemia (HP:0003233) | 4.12021294 |
26 | Abnormality of glycine metabolism (HP:0010895) | 4.07636079 |
27 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.07636079 |
28 | Abnormality of the common coagulation pathway (HP:0010990) | 4.07373258 |
29 | Aortic dissection (HP:0002647) | 4.04216954 |
30 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.04011801 |
31 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.82779916 |
32 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.82466574 |
33 | Vascular tortuosity (HP:0004948) | 3.78734322 |
34 | Vertebral compression fractures (HP:0002953) | 3.78673559 |
35 | Aortic aneurysm (HP:0004942) | 3.76940354 |
36 | Abnormality of methionine metabolism (HP:0010901) | 3.72141043 |
37 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.69987070 |
38 | Spinal rigidity (HP:0003306) | 3.61290524 |
39 | Ketoacidosis (HP:0001993) | 3.59672243 |
40 | Arterial tortuosity (HP:0005116) | 3.58401415 |
41 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.58056050 |
42 | Fat malabsorption (HP:0002630) | 3.57227301 |
43 | Increased variability in muscle fiber diameter (HP:0003557) | 3.56575534 |
44 | Abnormality of the intrinsic pathway (HP:0010989) | 3.53828684 |
45 | Abnormality of complement system (HP:0005339) | 3.50979923 |
46 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.45904978 |
47 | Ankle contracture (HP:0006466) | 3.41103734 |
48 | Hypercholesterolemia (HP:0003124) | 3.39454264 |
49 | Follicular hyperkeratosis (HP:0007502) | 3.29056985 |
50 | Dicarboxylic aciduria (HP:0003215) | 3.25836383 |
51 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.25836383 |
52 | Increased connective tissue (HP:0009025) | 3.25032356 |
53 | Wormian bones (HP:0002645) | 3.16645160 |
54 | Abnormality of serum amino acid levels (HP:0003112) | 3.07733468 |
55 | Hyperbilirubinemia (HP:0002904) | 3.05722855 |
56 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.05054635 |
57 | Mildly elevated creatine phosphokinase (HP:0008180) | 3.04296245 |
58 | Conjugated hyperbilirubinemia (HP:0002908) | 3.02317926 |
59 | Cervical subluxation (HP:0003308) | 3.01823271 |
60 | Slender build (HP:0001533) | 3.01801177 |
61 | Osteolytic defects of the hand bones (HP:0009699) | 2.94819589 |
62 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.94819589 |
63 | Metabolic acidosis (HP:0001942) | 2.89218348 |
64 | Exercise-induced myalgia (HP:0003738) | 2.88199567 |
65 | Skin nodule (HP:0200036) | 2.85869025 |
66 | Abnormality of nucleobase metabolism (HP:0010932) | 2.81064030 |
67 | Soft skin (HP:0000977) | 2.79074806 |
68 | Bladder diverticulum (HP:0000015) | 2.77587071 |
69 | Abnormal gallbladder physiology (HP:0012438) | 2.75452556 |
70 | Cholecystitis (HP:0001082) | 2.75452556 |
71 | Hepatocellular carcinoma (HP:0001402) | 2.75050491 |
72 | Lethargy (HP:0001254) | 2.74843130 |
73 | Myocardial infarction (HP:0001658) | 2.74566795 |
74 | Myoglobinuria (HP:0002913) | 2.70525395 |
75 | Hyporeflexia of lower limbs (HP:0002600) | 2.70192231 |
76 | Atrophic scars (HP:0001075) | 2.69431625 |
77 | Generalized aminoaciduria (HP:0002909) | 2.69392343 |
78 | Abnormality of purine metabolism (HP:0004352) | 2.69068727 |
79 | Hypoglycemic seizures (HP:0002173) | 2.68958326 |
80 | Steatorrhea (HP:0002570) | 2.68502369 |
81 | Delayed CNS myelination (HP:0002188) | 2.66972230 |
82 | Systemic lupus erythematosus (HP:0002725) | 2.66813442 |
83 | Spondylolisthesis (HP:0003302) | 2.65386599 |
84 | Cerebral edema (HP:0002181) | 2.60132474 |
85 | Dilatation of the ascending aorta (HP:0005111) | 2.59832425 |
86 | Distal lower limb muscle weakness (HP:0009053) | 2.59003955 |
87 | Round ear (HP:0100830) | 2.58303265 |
88 | Cerebral aneurysm (HP:0004944) | 2.56663293 |
89 | Abnormal gallbladder morphology (HP:0012437) | 2.53752245 |
90 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.52926063 |
91 | Blue sclerae (HP:0000592) | 2.51291463 |
92 | Neck muscle weakness (HP:0000467) | 2.50468936 |
93 | Elbow flexion contracture (HP:0002987) | 2.49299182 |
94 | Distal lower limb amyotrophy (HP:0008944) | 2.49053940 |
95 | Cholelithiasis (HP:0001081) | 2.48262240 |
96 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.46180249 |
97 | Abnormality of dentin (HP:0010299) | 2.43039477 |
98 | Exercise-induced muscle cramps (HP:0003710) | 2.38724515 |
99 | Asymmetric septal hypertrophy (HP:0001670) | 2.35263844 |
100 | Acanthocytosis (HP:0001927) | 2.34978002 |
101 | Fragile skin (HP:0001030) | 2.33561177 |
102 | Late onset (HP:0003584) | 2.32847691 |
103 | EMG: myopathic abnormalities (HP:0003458) | 2.32570331 |
104 | Renal cortical cysts (HP:0000803) | 2.30480918 |
105 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.30421158 |
106 | Abnormality of the acetabulum (HP:0003170) | 2.29936763 |
107 | Rhabdomyolysis (HP:0003201) | 2.29658441 |
108 | Abnormality of the calf musculature (HP:0001430) | 2.28716131 |
109 | Spontaneous abortion (HP:0005268) | 2.28049695 |
110 | Hypochromic microcytic anemia (HP:0004840) | 2.23572909 |
111 | Vascular calcification (HP:0004934) | 2.23457418 |
112 | Pancreatitis (HP:0001733) | 2.23080323 |
113 | Hydroxyprolinuria (HP:0003080) | 2.22965080 |
114 | Abnormality of proline metabolism (HP:0010907) | 2.22965080 |
115 | Lipoatrophy (HP:0100578) | 2.22839859 |
116 | Spastic diplegia (HP:0001264) | 2.21944787 |
117 | Vomiting (HP:0002013) | 2.21914805 |
118 | Generalized amyotrophy (HP:0003700) | 2.21596885 |
119 | Gout (HP:0001997) | 2.18606672 |
120 | Abnormal delivery (HP:0001787) | 2.16317415 |
121 | Glomerulonephritis (HP:0000099) | 2.15934734 |
122 | Peritonitis (HP:0002586) | 2.15712748 |
123 | Proximal tubulopathy (HP:0000114) | 2.15666933 |
124 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.14660919 |
125 | Muscle fiber splitting (HP:0003555) | 2.14098965 |
126 | Hypertriglyceridemia (HP:0002155) | 2.13806218 |
127 | Nausea (HP:0002018) | 2.13804827 |
128 | Irritability (HP:0000737) | 2.12922436 |
129 | Abnormality of glycolysis (HP:0004366) | 2.10453959 |
130 | Aneurysm (HP:0002617) | 2.10303976 |
131 | Ulnar deviation of the wrist (HP:0003049) | 2.09474493 |
132 | Neonatal onset (HP:0003623) | 2.09437870 |
133 | Brushfield spots (HP:0001088) | 2.09047983 |
134 | Glucose intolerance (HP:0000833) | 2.08001780 |
135 | Back pain (HP:0003418) | 2.07803514 |
136 | Mitral valve prolapse (HP:0001634) | 2.07711202 |
137 | Sensorimotor neuropathy (HP:0007141) | 2.06809423 |
138 | Short nail (HP:0001799) | 2.05662104 |
139 | Gingival bleeding (HP:0000225) | 2.04304829 |
140 | Abnormal cartilage morphology (HP:0002763) | 2.03245038 |
141 | Mitral stenosis (HP:0001718) | 2.02495731 |
142 | Hyperglycemia (HP:0003074) | 2.01761604 |
143 | Ovoid vertebral bodies (HP:0003300) | 2.00437715 |
144 | Amyloidosis (HP:0011034) | 2.00262482 |
145 | Cardiovascular calcification (HP:0011915) | 1.99856816 |
146 | Hemorrhage of the eye (HP:0011885) | 1.99630229 |
147 | Abnormality of the gallbladder (HP:0005264) | 1.98941762 |
148 | Menorrhagia (HP:0000132) | 1.98622080 |
149 | Achilles tendon contracture (HP:0001771) | 1.98167214 |
150 | Abnormality of the Achilles tendon (HP:0005109) | 1.97427008 |
151 | Muscle stiffness (HP:0003552) | 1.96655730 |
152 | Limb-girdle muscle atrophy (HP:0003797) | 1.96126802 |
153 | Mitral regurgitation (HP:0001653) | 1.95095737 |
154 | * Esophageal varix (HP:0002040) | 1.94539469 |
155 | Wrist flexion contracture (HP:0001239) | 1.93375055 |
156 | Elevated hepatic transaminases (HP:0002910) | 1.92363236 |
157 | Shallow orbits (HP:0000586) | 1.92233972 |
158 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.90396804 |
159 | Limb-girdle muscle weakness (HP:0003325) | 1.89909769 |
160 | Abnormality of iron homeostasis (HP:0011031) | 1.89396006 |
161 | Thrombophlebitis (HP:0004418) | 1.89146295 |
162 | Overgrowth (HP:0001548) | 1.89005096 |
163 | Biconcave vertebral bodies (HP:0004586) | 1.88603404 |
164 | Scapular winging (HP:0003691) | 1.87022121 |
165 | Increased serum pyruvate (HP:0003542) | 1.85567955 |
166 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.85185458 |
167 | Enlarged kidneys (HP:0000105) | 1.84568963 |
168 | Malnutrition (HP:0004395) | 1.83496146 |
169 | Bowel diverticulosis (HP:0005222) | 1.82247285 |
170 | Hepatic necrosis (HP:0002605) | 1.81782667 |
171 | Glycosuria (HP:0003076) | 1.81657335 |
172 | Abnormality of urine glucose concentration (HP:0011016) | 1.81657335 |
173 | Genu recurvatum (HP:0002816) | 1.80983151 |
174 | Aortic regurgitation (HP:0001659) | 1.80662092 |
175 | Opisthotonus (HP:0002179) | 1.80185338 |
176 | Disproportionate tall stature (HP:0001519) | 1.79969088 |
177 | Neonatal short-limb short stature (HP:0008921) | 1.76658647 |
178 | Joint laxity (HP:0001388) | 1.76137496 |
179 | Lower limb amyotrophy (HP:0007210) | 1.75307060 |
180 | Acanthosis nigricans (HP:0000956) | 1.74737531 |
181 | Difficulty climbing stairs (HP:0003551) | 1.72884238 |
182 | Distal upper limb amyotrophy (HP:0007149) | 1.71537270 |
183 | Upper limb amyotrophy (HP:0009129) | 1.71537270 |
184 | Distal arthrogryposis (HP:0005684) | 1.69636611 |
185 | Abnormality of carpal bone ossification (HP:0006257) | 1.69607117 |
186 | Joint stiffness (HP:0001387) | 1.69188720 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 6.18983869 |
2 | SIK1 | 4.00592210 |
3 | ERN1 | 3.52110815 |
4 | TRIB3 | 3.24632213 |
5 | PKN2 | 3.08074760 |
6 | FGFR4 | 3.01017494 |
7 | INSRR | 2.93545046 |
8 | FLT3 | 2.65180733 |
9 | DDR2 | 2.44846851 |
10 | MST1R | 2.33754691 |
11 | MOS | 2.19070535 |
12 | LATS2 | 2.16817466 |
13 | TAOK3 | 2.15274464 |
14 | OBSCN | 2.09344889 |
15 | SCYL2 | 2.08316389 |
16 | EIF2AK3 | 2.02323804 |
17 | PIK3CG | 2.01107770 |
18 | CAMK1D | 1.93162198 |
19 | EIF2AK1 | 1.88895035 |
20 | TRPM7 | 1.84872380 |
21 | ERBB4 | 1.84759210 |
22 | LIMK1 | 1.78964958 |
23 | MAP2K3 | 1.76938265 |
24 | NEK9 | 1.74091429 |
25 | PDK3 | 1.72906814 |
26 | PDK4 | 1.72906814 |
27 | PAK2 | 1.72383179 |
28 | TYK2 | 1.67723116 |
29 | MAPK11 | 1.55263601 |
30 | ARAF | 1.53229760 |
31 | KDR | 1.52621884 |
32 | PRKAA2 | 1.50681105 |
33 | MAP2K4 | 1.41209193 |
34 | ICK | 1.38690721 |
35 | TBK1 | 1.38448145 |
36 | FRK | 1.35279467 |
37 | MAP3K3 | 1.34747598 |
38 | PAK4 | 1.33613625 |
39 | SMG1 | 1.30106207 |
40 | PIM2 | 1.29729548 |
41 | PTK6 | 1.29621698 |
42 | TTN | 1.26736741 |
43 | TIE1 | 1.23278950 |
44 | TESK1 | 1.21388091 |
45 | LATS1 | 1.19491872 |
46 | CDK8 | 1.18170043 |
47 | PINK1 | 1.15864692 |
48 | JAK1 | 1.15773158 |
49 | ABL2 | 1.11649373 |
50 | EEF2K | 1.10737830 |
51 | MAP3K7 | 1.09882463 |
52 | NTRK1 | 1.08423106 |
53 | PRPF4B | 1.07413599 |
54 | JAK2 | 1.03496149 |
55 | IRAK3 | 1.03482468 |
56 | RIPK1 | 0.99888491 |
57 | TGFBR2 | 0.98085893 |
58 | CAMK1G | 0.96559747 |
59 | NME2 | 0.95838965 |
60 | PDGFRB | 0.94240183 |
61 | MAP3K14 | 0.93157361 |
62 | PDK2 | 0.90466302 |
63 | MET | 0.84741951 |
64 | FGFR3 | 0.84049912 |
65 | EPHB2 | 0.82315535 |
66 | PRKAA1 | 0.80383021 |
67 | MAPK4 | 0.80333271 |
68 | MAP3K6 | 0.76970085 |
69 | MAPK12 | 0.75573736 |
70 | MYLK | 0.74342857 |
71 | TGFBR1 | 0.74188356 |
72 | EPHB1 | 0.74147849 |
73 | KSR2 | 0.73970139 |
74 | CDK6 | 0.72383727 |
75 | IKBKE | 0.71927466 |
76 | EPHA2 | 0.70538737 |
77 | DAPK3 | 0.70384563 |
78 | MAP3K5 | 0.70254493 |
79 | LMTK2 | 0.69787208 |
80 | CSF1R | 0.69674530 |
81 | STK38 | 0.67579968 |
82 | MAP3K12 | 0.67328247 |
83 | MAPK7 | 0.66950440 |
84 | JAK3 | 0.65732514 |
85 | PHKG2 | 0.64948693 |
86 | PHKG1 | 0.64948693 |
87 | MAP2K6 | 0.64739999 |
88 | CSK | 0.63628193 |
89 | MAP3K11 | 0.63272977 |
90 | GSK3A | 0.62829487 |
91 | KIT | 0.62408067 |
92 | PRKACG | 0.61133234 |
93 | MAP3K10 | 0.59942294 |
94 | PIK3CA | 0.58079585 |
95 | ILK | 0.57707531 |
96 | EPHA3 | 0.57539710 |
97 | ACVR1B | 0.54093044 |
98 | CDK9 | 0.53819170 |
99 | PDPK1 | 0.53814610 |
100 | MAPKAPK5 | 0.53646344 |
101 | ROCK2 | 0.53553345 |
102 | MAP2K1 | 0.53135645 |
103 | MUSK | 0.51741889 |
104 | ZAP70 | 0.51100934 |
105 | AKT2 | 0.50633759 |
106 | STK38L | 0.49806848 |
107 | IGF1R | 0.49531265 |
108 | STK3 | 0.49524311 |
109 | ROCK1 | 0.48984349 |
110 | FGFR2 | 0.48940475 |
111 | RAF1 | 0.48862759 |
112 | MAP4K1 | 0.48761299 |
113 | GRK6 | 0.47362366 |
114 | ERBB3 | 0.47099989 |
115 | NEK1 | 0.46615999 |
116 | PAK6 | 0.45339793 |
117 | FER | 0.44803967 |
118 | PDK1 | 0.44320216 |
119 | DAPK2 | 0.44291154 |
120 | CAMK2G | 0.44006762 |
121 | CDC42BPA | 0.43640924 |
122 | CDK4 | 0.43293202 |
123 | WNK1 | 0.43011610 |
124 | SGK3 | 0.41032133 |
125 | ERBB2 | 0.40604232 |
126 | MELK | 0.39894064 |
127 | RET | 0.39687595 |
128 | DYRK1B | 0.39254417 |
129 | PTK2B | 0.39115993 |
130 | DMPK | 0.38371517 |
131 | CLK1 | 0.38105966 |
132 | PRKCZ | 0.37989915 |
133 | MAP3K8 | 0.37970639 |
134 | TAOK2 | 0.37735412 |
135 | MAPK15 | 0.36499389 |
136 | BTK | 0.34065219 |
137 | PDGFRA | 0.32599067 |
138 | PTK2 | 0.32559152 |
139 | TEC | 0.32386724 |
140 | MAP3K13 | 0.31965457 |
141 | MAPKAPK3 | 0.31657475 |
142 | PRKG2 | 0.31397355 |
143 | IRAK4 | 0.31067022 |
144 | PRKCQ | 0.31051841 |
145 | ITK | 0.30947133 |
146 | LRRK2 | 0.30688056 |
147 | EGFR | 0.30532846 |
148 | MTOR | 0.27977335 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.06496286 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.29202430 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.10327978 |
4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.03422361 |
5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.95093862 |
6 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.87377502 |
7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.81385507 |
8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.78616737 |
9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.69079599 |
10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.62881600 |
11 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.59786714 |
12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.57318030 |
13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.50895244 |
14 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.31869830 |
15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.25033652 |
16 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.22695341 |
17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.20040069 |
18 | Focal adhesion_Homo sapiens_hsa04510 | 2.17423533 |
19 | Peroxisome_Homo sapiens_hsa04146 | 2.15897848 |
20 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.13756342 |
21 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.12522000 |
22 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.10114345 |
23 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.98657226 |
24 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.94314877 |
25 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.88633695 |
26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.83735819 |
27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.76015941 |
28 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.75252814 |
29 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.73699697 |
30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.72014842 |
31 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.68695823 |
32 | Histidine metabolism_Homo sapiens_hsa00340 | 1.63300607 |
33 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.61586519 |
34 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.59119159 |
35 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.57155798 |
36 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.56786815 |
37 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.55624409 |
38 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.55620462 |
39 | Carbon metabolism_Homo sapiens_hsa01200 | 1.55063710 |
40 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.52656535 |
41 | Other glycan degradation_Homo sapiens_hsa00511 | 1.52497301 |
42 | Retinol metabolism_Homo sapiens_hsa00830 | 1.52158111 |
43 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.50116288 |
44 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.48551986 |
45 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.45615032 |
46 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.44294733 |
47 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.38212658 |
48 | * Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.34132977 |
49 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.34067895 |
50 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.33207910 |
51 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.32066084 |
52 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.29750262 |
53 | Bile secretion_Homo sapiens_hsa04976 | 1.27669498 |
54 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.23372766 |
55 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.20682163 |
56 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.17540785 |
57 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.17427695 |
58 | ABC transporters_Homo sapiens_hsa02010 | 1.17214287 |
59 | Bladder cancer_Homo sapiens_hsa05219 | 1.10613128 |
60 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.09159248 |
61 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.03445550 |
62 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.03020423 |
63 | Adherens junction_Homo sapiens_hsa04520 | 0.95779438 |
64 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.95270093 |
65 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.91531350 |
66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.89480186 |
67 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.88504043 |
68 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.87433924 |
69 | Sulfur relay system_Homo sapiens_hsa04122 | 0.86881705 |
70 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.86742256 |
71 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.86333460 |
72 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.84962378 |
73 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.84084474 |
74 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.80818979 |
75 | Lysine degradation_Homo sapiens_hsa00310 | 0.80703015 |
76 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.79465759 |
77 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.78431681 |
78 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.76028733 |
79 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.74298277 |
80 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.72480997 |
81 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.72168564 |
82 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.71216725 |
83 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.67328691 |
84 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.66392073 |
85 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.65399321 |
86 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.63035378 |
87 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.61457507 |
88 | Melanoma_Homo sapiens_hsa05218 | 0.59449705 |
89 | Shigellosis_Homo sapiens_hsa05131 | 0.56839126 |
90 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.55996630 |
91 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.54421914 |
92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.53728592 |
93 | Thyroid cancer_Homo sapiens_hsa05216 | 0.50946966 |
94 | Insulin resistance_Homo sapiens_hsa04931 | 0.50626554 |
95 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.47211652 |
96 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.47034197 |
97 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.45458332 |
98 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.44379460 |
99 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.43167216 |
100 | Galactose metabolism_Homo sapiens_hsa00052 | 0.40415984 |
101 | Viral myocarditis_Homo sapiens_hsa05416 | 0.37983092 |
102 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.36225302 |
103 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.35193497 |
104 | Circadian rhythm_Homo sapiens_hsa04710 | 0.34780548 |
105 | Pathways in cancer_Homo sapiens_hsa05200 | 0.32524571 |
106 | Glioma_Homo sapiens_hsa05214 | 0.29857628 |
107 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.28915677 |
108 | Hepatitis B_Homo sapiens_hsa05161 | 0.27563893 |
109 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.26729486 |
110 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.24855354 |
111 | Prion diseases_Homo sapiens_hsa05020 | 0.22948485 |
112 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.19127577 |
113 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17068289 |
114 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.12995427 |
115 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.11965791 |
116 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.05984320 |
117 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.05457585 |
118 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.01055857 |
119 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.2073123 |
120 | Malaria_Homo sapiens_hsa05144 | -0.1933839 |
121 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1902515 |
122 | Amoebiasis_Homo sapiens_hsa05146 | -0.1703590 |
123 | Lysosome_Homo sapiens_hsa04142 | -0.1670655 |
124 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1567441 |
125 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.1567093 |
126 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1527753 |
127 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1489314 |
128 | Pertussis_Homo sapiens_hsa05133 | -0.1405667 |
129 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1277329 |
130 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1232205 |
131 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.1207265 |
132 | Hepatitis C_Homo sapiens_hsa05160 | -0.1097145 |
133 | Legionellosis_Homo sapiens_hsa05134 | -0.0997100 |
134 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.0769063 |
135 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0385387 |